The Evolution of Triple-Negative Breast Cancer Therapy

Advancements in Oncology panelist Margaret Gatti-Mays, MD, MPH, adds to her post-panel wrap-up on breast cancer innovations by detailing how treatment for triple-negative breast cancer has evolved in recent years, especially with the emergence of immunotherapy.